As previously noted, NSCLC patient tumor samples showed higher expression of the different enzymes of the de novo ser/gly synthesis pathway, i.e. PHGDH, PSAT1, PSPH and SHMT2, compared to the adjacent normal lung tissue, which hardly showed any expression of ser/gly pathway enzymes. The gene discussed is PSAT1; the disease is non-small cell lung carcinoma.